Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;22(6):766-767.
doi: 10.1016/S1473-3099(22)00224-9. Epub 2022 Apr 12.

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3

Prerna Arora  1 , Lu Zhang  1 , Cheila Rocha  1 , Anzhalika Sidarovich  1 , Amy Kempf  1 , Sebastian Schulz  2 , Anne Cossmann  3 , Bernhard Manger  4 , Eva Baier  5 , Björn Tampe  5 , Onnen Moerer  6 , Steffen Dickel  6 , Alexandra Dopfer-Jablonka  7 , Hans-Martin Jäck  2 , Georg M N Behrens  7 , Martin S Winkler  6 , Stefan Pöhlmann  1 , Markus Hoffmann  8
Affiliations

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3

Prerna Arora et al. Lancet Infect Dis. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

SP acknowledges funding from Bundesministerium für Bildung und Forschung (BMBF; grant numbers 01KI2006D, 01KI20328A, 01KX2021), the Ministry for Science and Culture of Lower Saxony (grant numbers 14-76103-184, MWK HZI COVID-19), and the German Research Foundation (DFG; grant numbers PO 716/11-1, PO 716/14-1). MSW received unrestricted funding from Sartorius, Lung research. H-MJ received funding from BMBF (grant numbers 01KI2043, NaFoUniMedCovid19-COVIM 01KX2021), Bavarian State Ministry for Science and the Arts, and DFG through the research training groups RTG1660 and TRR130, the Bayerische Forschungsstiftung (Project CORAd), and the Kastner Foundation. GMNB acknowledges funding from the German Center for Infection Research (grant number 80018019238) and a European Regional Development Fund (Defeat Corona, grant number ZW7-8515131, together with AD-J). All other authors declare no competing interests.

References

    1. Hoffmann M, Krüger N, Schulz S, et al. The omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185:447–456. - PMC - PubMed
    1. Altarawneh HN, Chemaitelly H, Hasan MR, et al. Protection against the omicron variant from previous SARS-CoV-2 infection. N Engl J Med. 2022 doi: 10.1056/NEJMc2200133. published online Feb 9. - DOI - PMC - PubMed
    1. Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N Engl J Med. 2022;386:494–496. - PMC - PubMed
    1. Mahase E. COVID-19: what do we know about omicron sublineages? BMJ. 2022;376:o358. - PubMed
    1. McCallum M, De Marco A, Lempp FA, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184:2332–2347. - PMC - PubMed

Publication types

Substances